加茂 直子

最終更新日時: 2019/06/18 21:27:24

印刷する

氏名(漢字/フリガナ/アルファベット表記)
加茂 直子/カモ ナオコ/Kamo, Naoko
所属部署・職名(部局/所属/講座等/職名)
医学部附属病院/外科(肝胆膵・移植外科)/助教
所属学会(国内)
学会名(日本語) 学会名(英語)
日本外科学会 Japan Surgical Society
日本消化器外科学会 The Japanese Society of Gastroenterological Surgery
日本肝胆膵外科学会 Japanese Society of Hepato-Biliary-Pancreatic Surgery
日本内視鏡外科学会 Japan society of endoscopic surgery
日本臨床外科学会 Japan surgical association
日本内分泌外科学会
日本神経内分泌腫瘍研究会
日本移植学会 The Japan Society for Transplantation
日本静脈経腸栄養学会
日本外科感染症学会
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(医学) 京都大学
出身大学院・研究科等
大学名(日本語) 大学名(英語) 研究科名(日本語) 研究科名(英語) 専攻名(日本語) 専攻名(英語) 修了区分
京都大学 大学院医学研究科博士課程外科系専攻 修了
researchmap URL
https://researchmap.jp/7000011455
研究テーマ
(日本語)
肝再生、虚血再灌流障害、サルコペニア
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Ann Surg, 269, 5, 924-931 Ann Surg, 269, 5, 924-931 Ann Surg, 269, 5, 924-931 2019/05 公開
Kaido T, Kamo N, Uemoto S Kaido T, Kamo N, Uemoto S Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Clin Nutr, 38, 2, 967 Clin Nutr, 38, 2, 967 Clin Nutr, 38, 2, 967 2019/04 公開
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma Liver Cancer, 8, 2, 92-109 Liver Cancer, 8, 2, 92-109 Liver Cancer, 8, 2, 92-109 2019/03 公開
Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma. Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma. Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma. World J Surg, 43, 3, 920-928 World J Surg, 43, 3, 920-928 World J Surg, 43, 3, 920-928 2019/03 公開
Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated Am J Transplant Am J Transplant Am J Transplant 2019/03 公開
Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience Hepatol Res Hepatol Res Hepatol Res 2019/01 公開
Kamo N, Kaido T, Uozumi R, Yagi S, Okajima H, Uemoto S Kamo N, Kaido T, Uozumi R, Yagi S, Okajima H, Uemoto S Preoperative Ascites and/or Pleural Effusion Was a Predictor Preoperative Ascites and/or Pleural Effusion Was a Predictor Preoperative Ascites and/or Pleural Effusion Was a Predictor Surg. Gastroenterol. Oncol., 24, 1, 22-30 Surg. Gastroenterol. Oncol., 24, 1, 22-30 Surg. Gastroenterol. Oncol., 24, 1, 22-30 2019 公開
Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clin Nutr Clin Nutr Clin Nutr 2018/12 公開
Badawy A, Kaido T, Hammad A, Yagi S, Kamo N, Yoshizawa A, Okajima H, Uemoto S Badawy A, Kaido T, Hammad A, Yagi S, Kamo N, Yoshizawa A, Okajima H, Uemoto S Badawy A, Kaido T, Hammad A, Yagi S, Kamo N, Yoshizawa A, Okajima H, Uemoto S The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation. The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation. The Impact of Preoperative Hemoglobin Level on the Short-Term Outcomes After Living Donor Liver Transplantation. World J Surg, 42, 12, 4081-4089 , 42, 12, 4081-4089 World J Surg, 42, 12, 4081-4089 2018/12 公開
Kamo N, Kaido T, Hamaguchi Y, Uozumi R, Okumura S, Kobayashi A, Shirai H, Yagi S, Okajima H, Uemoto S Kamo N, Kaido T, Hamaguchi Y, Uozumi R, Okumura S, Kobayashi A, Shirai H, Yagi S, Okajima H, Uemoto S Impact of Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Infection After Liver Transplantation. Impact of Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Infection After Liver Transplantation. Impact of Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Infection After Liver Transplantation. World J Surg, 42, 11, 3715-3725 World J Surg, 42, 11, 3715-3725 World J Surg, 42, 11, 3715-3725 2018/11 公開
Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S Is Portal Venous Pressure Modulation Still Indicated for All Recipients in Living Donor Liver Transplantation? Is Portal Venous Pressure Modulation Still Indicated for All Recipients in Living Donor Liver Transplantation? Is Portal Venous Pressure Modulation Still Indicated for All Recipients in Living Donor Liver Transplantation? Liver Transpl, 24, 11, 1578-1588 Liver Transpl, 24, 11, 1578-1588 Liver Transpl, 24, 11, 1578-1588 2018/11 公開
Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation? Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation? Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation? Prog Transplant, 28, 3, 213-219 Prog Transplant, 28, 3, 213-219 Prog Transplant, 28, 3, 213-219 2018/09 公開
Kamo N, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Uemoto S Kamo N, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Uemoto S Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. 2018/07 公開
Badawy A, Kaido T, Atsushi Y, Yagi S, Hata K, Kamo N, Fukumitsu K, Okajima H, Uemoto S Badawy A, Kaido T, Atsushi Y, Yagi S, Hata K, Kamo N, Fukumitsu K, Okajima H, Uemoto S Evans Syndrome After Successful Immunosuppressant-Free Living-Donor Liver Transplant. Evans Syndrome After Successful Immunosuppressant-Free Living-Donor Liver Transplant. Evans Syndrome After Successful Immunosuppressant-Free Living-Donor Liver Transplant. Exp Clin Transplant Exp Clin Transplant Exp Clin Transplant 2018/06 公開
Aliyev V, Yagi S, Hammad A, Badawy A, Sasaki Y, Masano Y, Yamamoto G, Kamo N, Taura K, Okajima H, Kaido T, Uemoto S Aliyev V, Yagi S, Hammad A, Badawy A, Sasaki Y, Masano Y, Yamamoto G, Kamo N, Taura K, Okajima H, Kaido T, Uemoto S Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience. Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience. Sclerosing encapsulating peritonitis after living-donor liver transplantation: A case series, Kyoto experience. Ann Hepatobiliary Pancreat Surg, 22, 2, 144-149 Ann Hepatobiliary Pancreat Surg, 22, 2, 144-149 Ann Hepatobiliary Pancreat Surg, 22, 2, 144-149 2018/05 公開
Kamo N, Kaido T, Yagi S, Okajima H, Uemoto S Kamo N, Kaido T, Yagi S, Okajima H, Uemoto S Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma. Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma. Liver Transplantation for Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer, 7, 2, 179-189 Liver Cancer, 7, 2, 179-189 Liver Cancer, 7, 2, 179-189 2018/05 公開
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases World J Surg, 42, 4, 1180-1191 World J Surg, 42, 4, 1180-1191 World J Surg, 42, 4, 1180-1191 2018/04 公開
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Okajima H, Uemoto S Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Okajima H, Uemoto S Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle, 9, 2, 246 J Cachexia Sarcopenia Muscle, 9, 2, 246 J Cachexia Sarcopenia Muscle, 9, 2, 246 2018/04 公開
Shirai H, Kaido T, Hamaguchi Y, Kobayashi A, Okumura S, Yao S, Yagi S, Kamo N, Taura K, Okajima H, Uemoto S Shirai H, Kaido T, Hamaguchi Y, Kobayashi A, Okumura S, Yao S, Yagi S, Kamo N, Taura K, Okajima H, Uemoto S Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Liver Cancer, 7, 1, 76-89 Liver Cancer, 7, 1, 76-89 Liver Cancer, 7, 1, 76-89 2018/03 公開
Okamura Y, Yagi S, Sato T, Hata K, Ogawa E, Yoshizawa A, Kamo N, Yamashiki N, Okajima H, Kaido T, Uemoto S Okamura Y, Yagi S, Sato T, Hata K, Ogawa E, Yoshizawa A, Kamo N, Yamashiki N, Okajima H, Kaido T, Uemoto S Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation. Transplantation, 102, 3, 440-447 Transplantation, 102, 3, 440-447 Transplantation, 102, 3, 440-447 2018/03 公開
Shirai H, Kaido T, Hamaguchi Y, Yao S, Kobayashi A, Okumura S, Kamo N, Yagi S, Okajima H, Uemoto S Shirai H, Kaido T, Hamaguchi Y, Yao S, Kobayashi A, Okumura S, Kamo N, Yagi S, Okajima H, Uemoto S Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation. Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation. Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation. Nutrition, 45, 1-10 Nutrition, 45, 1-10 Nutrition, 45, 1-10 2018/01 公開
Hammad A, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Kamo N, Yagi S, Uemoto S Hammad A, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Kamo N, Yagi S, Uemoto S Impact of sarcopenic overweight on the outcomes after living donor liver transplantation. Impact of sarcopenic overweight on the outcomes after living donor liver transplantation. Impact of sarcopenic overweight on the outcomes after living donor liver transplantation. Hepatobiliary Surg Nutr, 6, 6, 367-378 Hepatobiliary Surg Nutr, 6, 6, 367-378 Hepatobiliary Surg Nutr, 6, 6, 367-378 2017/12 公開
Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Hatano E, Okajima H, Takaori K, Uemoto S Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Hatano E, Okajima H, Takaori K, Uemoto S Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer. Ann Surg Oncol, 24, 12, 3732-3740 Ann Surg Oncol, 24, 12, 3732-3740 Ann Surg Oncol, 24, 12, 3732-3740 2017/11 公開
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, Kamo N, Okajima H, Uemoto S Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, Kamo N, Okajima H, Uemoto S Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation. Transplantation, 101, 3, 565-574 Transplantation, 101, 3, 565-574 , 101, 3, 565-574 2017/03 公開
Kaido T, Tamai Y, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yagi S, Kamo N, Hammad A, Inagaki N, Uemoto S Kaido T, Tamai Y, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yagi S, Kamo N, Hammad A, Inagaki N, Uemoto S Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Nutrition, 33, 195-198 Nutrition, 33, 195-198 Nutrition, 33, 195-198 2017/01 公開
Iwaki K, Kaido T, Yamamoto G, Kamo N, Yagi S, Taura K, Uemoto S Iwaki K, Kaido T, Yamamoto G, Kamo N, Yagi S, Taura K, Uemoto S Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report. Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report. Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report. Int J Surg Case Rep, 40, 13-16 Int J Surg Case Rep, 40, 13-16 , 40, 13-16 2017 公開
Kamo N, Kaido T, Shintaro Y, Okajima H, Uemoto S Kamo N, Kaido T, Shintaro Y, Okajima H, Uemoto S Impact of younger donors on outcomes after living donor liver transplantation Impact of younger donors on outcomes after living donor liver transplantation Impact of younger donors on outcomes after living donor liver transplantation Transplant Open, 2, 1-5 Transplant Open, 2, 1-5 Transplant Open, 2, 1-5 2017 公開
Kamo N, Kaido T, Yagi S, Okajima H, Uemoto S Kamo N, Kaido T, Yagi S, Okajima H, Uemoto S Liver transplantation for small hepatocellular carcinoma. Liver transplantation for small hepatocellular carcinoma. Liver transplantation for small hepatocellular carcinoma. Hepatobiliary Surg Nutr, 5, 5, 391-398 Hepatobiliary Surg Nutr, 5, 5, 391-398 Hepatobiliary Surg Nutr, 5, 5, 391-398 2016/10 公開
Kamo N, Kaido T, Hammad A, Ogawa K, Fujimoto Y, Uemura T, Mori A, Hatano E, Okajima H, Uemoto S Kamo N, Kaido T, Hammad A, Ogawa K, Fujimoto Y, Uemura T, Mori A, Hatano E, Okajima H, Uemoto S Kamo N, Kaido T, Hammad A, Ogawa K, Fujimoto Y, Uemura T, Mori A, Hatano E, Okajima H, Uemoto S Impact of elderly donors for liver transplantation: A single-center experience. Impact of elderly donors for liver transplantation: A single-center experience. Impact of elderly donors for liver transplantation: A single-center experience. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 21, 5, 591-598 Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 21, 5, 591-598 Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 21, 5, 591-598 2015/05 公開
Ke B, Shen XD, Zhang Y, Ji H, Gao F, Yue S, Kamo N, Zhai Y, Yamamoto M, Busuttil RW, Kupiec-Weglinski JW Ke B, Shen XD, Zhang Y, Ji H, Gao F, Yue S, Kamo N, Zhai Y, Yamamoto M, Busuttil RW, Kupiec-Weglinski JW Ke B, Shen XD, Zhang Y, Ji H, Gao F, Yue S, Kamo N, Zhai Y, Yamamoto M, Busuttil RW, Kupiec-Weglinski JW KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants. KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants. KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants. Journal of hepatology, 59, 6, 1200-1207 Journal of hepatology, 59, 6, 1200-1207 Journal of hepatology, 59, 6, 1200-1207 2013/12 公開
Kupiec-Weglinski JW, Kamo N Kupiec-Weglinski JW, Kamo N Kupiec-Weglinski JW, Kamo N Reply: To PMID 23408710. Reply: To PMID 23408710. Reply: To PMID 23408710. Hepatology (Baltimore, Md.), 58, 6, 2212-2213 Hepatology (Baltimore, Md.), 58, 6, 2212-2213 Hepatology (Baltimore, Md.), 58, 6, 2212-2213 2013/12 公開
Kamo N, Ke B, Ghaffari AA, Shen XD, Busuttil RW, Cheng G, Kupiec-Weglinski JW Kamo N, Ke B, Ghaffari AA, Shen XD, Busuttil RW, Cheng G, Kupiec-Weglinski JW Kamo N, Ke B, Ghaffari AA, Shen XD, Busuttil RW, Cheng G, Kupiec-Weglinski JW ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology (Baltimore, Md.), 58, 1, 351-362 Hepatology (Baltimore, Md.), 58, 1, 351-362 Hepatology (Baltimore, Md.), 58, 1, 351-362 2013/07 公開
Ke B, Shen XD, Kamo N, Ji H, Yue S, Gao F, Busuttil RW, Kupiec-Weglinski JW Ke B, Shen XD, Kamo N, Ji H, Yue S, Gao F, Busuttil RW, Kupiec-Weglinski JW Ke B, Shen XD, Kamo N, Ji H, Yue S, Gao F, Busuttil RW, Kupiec-Weglinski JW β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. Hepatology (Baltimore, Md.), 57, 3, 1203-1214 Hepatology (Baltimore, Md.), 57, 3, 1203-1214 Hepatology (Baltimore, Md.), 57, 3, 1203-1214 2013/03 公開
Kamo N, Ke B, Busuttil RW, Kupiec-Weglinski JW Kamo N, Ke B, Busuttil RW, Kupiec-Weglinski JW Kamo N, Ke B, Busuttil RW, Kupiec-Weglinski JW PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury. Hepatology (Baltimore, Md.), 57, 1, 289-298 Hepatology (Baltimore, Md.), 57, 1, 289-298 Hepatology (Baltimore, Md.), 57, 1, 289-298 2013/01 公開
Ke B, Shen XD, Ji H, Kamo N, Gao F, Freitas MC, Busuttil RW, Kupiec-Weglinski JW Ke B, Shen XD, Ji H, Kamo N, Gao F, Freitas MC, Busuttil RW, Kupiec-Weglinski JW Ke B, Shen XD, Ji H, Kamo N, Gao F, Freitas MC, Busuttil RW, Kupiec-Weglinski JW HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. Journal of hepatology, 56, 2, 359-366 Journal of hepatology, 56, 2, 359-366 Journal of hepatology, 56, 2, 359-366 2012/02 公開
Kamo N, Shen XD, Ke B, Busuttil RW, Kupiec-Weglinski JW. Kamo N, Shen XD, Ke B, Busuttil RW, Kupiec-Weglinski JW. Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation. Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation. Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation. Am J Transplant, 11, 11, 2499-2507 Am J Transplant, 11, 11, 2499-2507 Am J Transplant, 11, 11, 2499-2507 2011/11 英語 研究論文(学術雑誌) 公開
Kamo N, Mori A, Nitta T, Hatano E, Mitsuyoshi H, Ikeda K, Uemoto S Kamo N, Mori A, Nitta T, Hatano E, Mitsuyoshi H, Ikeda K, Uemoto S Kamo N, Mori A, Nitta T, Hatano E, Mitsuyoshi H, Ikeda K, Uemoto S [Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy]. [Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy]. [Two cases of curatively resected intrahepatic cholangiocellular carcinomas through effective response to neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 38, 2, 305-308 Gan to kagaku ryoho. Cancer & chemotherapy, 38, 2, 305-308 Gan to kagaku ryoho. Cancer & chemotherapy, 38, 2, 305-308 2011/02 公開
Konishi S, Yasuchika K, Ishii T, Fukumitsu K, Kamo N, Fujita N, Ikai I, Uemoto S Konishi S, Yasuchika K, Ishii T, Fukumitsu K, Kamo N, Fujita N, Ikai I, Uemoto S Konishi S, Yasuchika K, Ishii T, Fukumitsu K, Kamo N, Fujita N, Ikai I, Uemoto S A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers. A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers. A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers. In vitro cellular & developmental biology. Animal, 47, 1, 45-53 In vitro cellular & developmental biology. Animal, 47, 1, 45-53 In vitro cellular & developmental biology. Animal, 47, 1, 45-53 2011/01 公開
Hori T, Nguyen JH, Zhao X, Ogura Y, Hata T, Yagi S, Chen F, Baine AM, Ohashi N, Eckman CB, Herdt AR, Egawa H, Takada Y, Oike F, Sakamoto S, Kasahara M, Ogawa K, Hata K, Iida T, Yonekawa Y, Sibulesky L, Kuribayashi K, Kato T, Saito K, Wang L, Torii M, Sahara N, Kamo N, Sahara T, Yasutomi M, Uemoto S Hori T, Nguyen JH, Zhao X, Ogura Y, Hata T, Yagi S, Chen F, Baine AM, Ohashi N, Eckman CB, Herdt AR, Egawa H, Takada Y, Oike F, Sakamoto S, Kasahara M, Ogawa K, Hata K, Iida T, Yonekawa Y, Sibulesky L, Kuribayashi K, Kato T, Saito K, Wang L, Torii M, Sahara N, Kamo N, Sahara T, Yasutomi M, Uemoto S Hori T, Nguyen JH, Zhao X, Ogura Y, Hata T, Yagi S, Chen F, Baine AM, Ohashi N, Eckman CB, Herdt AR, Egawa H, Takada Y, Oike F, Sakamoto S, Kasahara M, Ogawa K, Hata K, Iida T, Yonekawa Y, Sibulesky L, Kuribayashi K, Kato T, Saito K, Wang L, Torii M, Sahara N, Kamo N, Sahara T, Yasutomi M, Uemoto S Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide. Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide. Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide. World journal of gastroenterology : WJG, 16, 25, 3120-3132 World journal of gastroenterology : WJG, 16, 25, 3120-3132 World journal of gastroenterology : WJG, 16, 25, 3120-3132 2010/07 公開
Imai H, Doi R, Kanazawa H, Kamo N, Koizumi M, Masui T, Iwanaga Y, Kawaguchi Y, Takada Y, Isoda H, Uemoto S Imai H, Doi R, Kanazawa H, Kamo N, Koizumi M, Masui T, Iwanaga Y, Kawaguchi Y, Takada Y, Isoda H, Uemoto S Imai H, Doi R, Kanazawa H, Kamo N, Koizumi M, Masui T, Iwanaga Y, Kawaguchi Y, Takada Y, Isoda H, Uemoto S Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. International journal of clinical oncology, 15, 3, 294-300 International journal of clinical oncology, 15, 3, 294-300 International journal of clinical oncology, 15, 3, 294-300 2010/06 公開
Kamo N, Kaido T, Mori A, Hatano E, Takada Y, Egawa H, Uemoto S Kamo N, Kaido T, Mori A, Hatano E, Takada Y, Egawa H, Uemoto S Kamo N, Kaido T, Mori A, Hatano E, Takada Y, Egawa H, Uemoto S Factors affecting postoperative hyperbilirubinemia in the donor after living donor liver transplantation. Factors affecting postoperative hyperbilirubinemia in the donor after living donor liver transplantation. Factors affecting postoperative hyperbilirubinemia in the donor after living donor liver transplantation. Hepato-gastroenterology, 56, 91-92, 840-843 Hepato-gastroenterology, 56, 91-92, 840-843 Hepato-gastroenterology, 56, 91-92, 840-843 2009/05 公開
Ishii T, Yasuchika K, Machimoto T, Kamo N, Komori J, Konishi S, Suemori H, Nakatsuji N, Saito M, Kohno K, Uemoto S, Ikai I Ishii T, Yasuchika K, Machimoto T, Kamo N, Komori J, Konishi S, Suemori H, Nakatsuji N, Saito M, Kohno K, Uemoto S, Ikai I Ishii T, Yasuchika K, Machimoto T, Kamo N, Komori J, Konishi S, Suemori H, Nakatsuji N, Saito M, Kohno K, Uemoto S, Ikai I Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem cells (Dayton, Ohio), 25, 12, 3252-3260 Stem cells (Dayton, Ohio), 25, 12, 3252-3260 Stem cells (Dayton, Ohio), 25, 12, 3252-3260 2007/12 公開
Machimoto T, Yasuchika K, Komori J, Ishii T, Kamo N, Shimoda M, Konishi S, Saito M, Kohno K, Uemoto S, Ikai I Machimoto T, Yasuchika K, Komori J, Ishii T, Kamo N, Shimoda M, Konishi S, Saito M, Kohno K, Uemoto S, Ikai I Machimoto T, Yasuchika K, Komori J, Ishii T, Kamo N, Shimoda M, Konishi S, Saito M, Kohno K, Uemoto S, Ikai I Improvement of the survival rate by fetal liver cell transplantation in a mice lethal liver failure model. Improvement of the survival rate by fetal liver cell transplantation in a mice lethal liver failure model. Improvement of the survival rate by fetal liver cell transplantation in a mice lethal liver failure model. Transplantation, 84, 10, 1233-1239 Transplantation, 84, 10, 1233-1239 Transplantation, 84, 10, 1233-1239 2007/11 公開
Kamo N, Yasuchika K, Fujii H, Hoppo T, Machimoto T, Ishii T, Fujita N, Tsuruo T, Yamashita JK, Kubo H, Ikai I Kamo N, Yasuchika K, Fujii H, Hoppo T, Machimoto T, Ishii T, Fujita N, Tsuruo T, Yamashita JK, Kubo H, Ikai I Kamo N, Yasuchika K, Fujii H, Hoppo T, Machimoto T, Ishii T, Fujita N, Tsuruo T, Yamashita JK, Kubo H, Ikai I Two populations of Thy1-positive mesenchymal cells regulate in vitro maturation of hepatic progenitor cells. Two populations of Thy1-positive mesenchymal cells regulate in vitro maturation of hepatic progenitor cells. Two populations of Thy1-positive mesenchymal cells regulate in vitro maturation of hepatic progenitor cells. American journal of physiology. Gastrointestinal and liver physiology, 292, 2, G526-34 American journal of physiology. Gastrointestinal and liver physiology, 292, 2, G526-34 American journal of physiology. Gastrointestinal and liver physiology, 292, 2, G526-34 2007/02 公開
Seo S, Miki A, Iwaisako K, Kamo N, Inomoto T, Kitai T, Ukikusa M Seo S, Miki A, Iwaisako K, Kamo N, Inomoto T, Kitai T, Ukikusa M Seo S, Miki A, Iwaisako K, Kamo N, Inomoto T, Kitai T, Ukikusa M [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer]. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer]. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 33, 11, 1579-1582 Gan to kagaku ryoho. Cancer & chemotherapy, 33, 11, 1579-1582 Gan to kagaku ryoho. Cancer & chemotherapy, 33, 11, 1579-1582 2006/11 公開
Ishii T, Yasuchika K, Fujii H, Hoppo T, Baba S, Naito M, Machimoto T, Kamo N, Suemori H, Nakatsuji N, Ikai I Ishii T, Yasuchika K, Fujii H, Hoppo T, Baba S, Naito M, Machimoto T, Kamo N, Suemori H, Nakatsuji N, Ikai I Ishii T, Yasuchika K, Fujii H, Hoppo T, Baba S, Naito M, Machimoto T, Kamo N, Suemori H, Nakatsuji N, Ikai I In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes. In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes. In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes. Experimental cell research, 309, 1, 68-77 Experimental cell research, 309, 1, 68-77 Experimental cell research, 309, 1, 68-77 2005/09 公開

  • <<
  • >>
  • 表示
タイトル言語:
学術賞等
賞の名称(日本語) 賞の名称(英語) 授与組織名(日本語) 授与組織名(英語) 年月
Young Investigator Award,17th annual congress of the International Liver Transplantation Society International Liver Transplantation Society 2011/06/22
優秀演題賞 日本肝移植研究会 2016/07/07